Evidence map›Paper›PMID 37227784›Full record

ArticleThe Journal of clinical investigation2023

Single-cell transcriptomic analysis of renal allograft rejection reveals insights into intragraft TCR clonality.

Tiffany Shi, Ashley R Burg, J Timothy Caldwell, Krishna M Roskin, Cyd M Castro-Rojas, P Chukwunalu Chukwuma, George I Gray, Sara G Foote, Jesus A Alonso, Carla M Cuda and 9 more

Open access · goldAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 1 pooled it
11.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. bioRxiv : the preprint server for biology · 2026
    Article
  4. Article
  5. CD8Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Article
  6. Article
  7. Article
  8. Targeted Expansion of Treg Cells to Induce Immune Tolerance after Kidney Transplantation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  9. Review
  10. Article
  11. Single-cell transcriptional landscape of liver transplant rejection reveals tissue persistence of clonally expanded, treatment-resistant T cells.American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons · 2025
    Article
  12. Article
  13. Resolving ScRNA-Seq Signatures of Antigen-Specific CD4bioRxiv : the preprint server for biology · 2025
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 7 institutions in 2 countries.

Tiffany ShiDivision of Immunobiology and.
Ashley R BurgDivision of Immunobiology and.
J Timothy CaldwellDivision of Nephrology and Hypertension and.
Krishna M RoskinDivision of Immunobiology and.
Cyd M Castro-RojasDivision of Immunobiology and.
P Chukwunalu ChukwumaDepartment of Chemistry and Biochemistry and the Harper Cancer Research Institute, University of Notre Dame, Notre Dame, Indiana, USA.
George I GrayDepartment of Chemistry and Biochemistry and the Harper Cancer Research Institute, University of Notre Dame, Notre Dame, Indiana, USA.
Sara G FooteDepartment of Chemistry and Biochemistry and the Harper Cancer Research Institute, University of Notre Dame, Notre Dame, Indiana, USA.
Jesus A AlonsoDepartment of Chemistry and Biochemistry and the Harper Cancer Research Institute, University of Notre Dame, Notre Dame, Indiana, USA.
Carla M CudaNorthwestern University, Feinberg School of Medicine, Department of Medicine, Division of Rheumatology, Chicago, Illinois, USA.
David A AllmanUniversity of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
James S RushNovartis Institutes for Biomedical Research, Immunology Disease Area, Basel, Switzerland.
Catherine H RegnierNovartis Institutes for Biomedical Research, Immunology Disease Area, Basel, Switzerland.
Grazyna WieczorekNovartis Institutes for Biomedical Research, Immunology Disease Area, Basel, Switzerland.
Rita R AllowayDivision of Nephrology and Hypertension, Department of Internal Medicine, and.
Adele R ShieldsDivision of Transplantation, Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
Brian M BakerDepartment of Chemistry and Biochemistry and the Harper Cancer Research Institute, University of Notre Dame, Notre Dame, Indiana, USA.
E Steve WoodleDivision of Transplantation, Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA.
David A HildemanDivision of Immunobiology and.
Cincinnati Children's Hospital Medical Center · USUniversity of Notre Dame · USNovartis (Switzerland) · CHUniversity of Cincinnati Medical Center · USHypertension Institute · USNorthwestern University · USUniversity of Pennsylvania · US

Funding

Cincinnati Center for Clinical and Translational Sciences and TrainingUL1TR000077 · NCATS · UNIVERSITY OF CINCINNATI · PI HEUBI, JAMES E., TSEVAT, JOEL · 2012 to 2014
$9.9M
PEARL: Pathway Exploration and Analysis in Renal LupusUH2AR067688 · NIAMS · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI DIAMOND, BETTY, WOFSY, DAVID · 2014 to 2020
$9.0M
RESEARCH TRAINING IN PEDIATRIC NEPHROLOGYT32DK007695 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI DEVARAJAN, PRASAD · 1992 to 2023
$2.2M
Decoding human T-cell allospecificityR21AI169863 · NIAID · UNIVERSITY OF NOTRE DAME · PI BAKER, BRIAN M, HILDEMAN, DAVID A · 2023 to 2024
$464k
Single cell analysis of transplant rejectionR21AI142264 · NIAID · CINCINNATI CHILDRENS HOSP MED CTR · PI HILDEMAN, DAVID A · 2019 to 2020
$452k
Single Cell Analysis of Allowance CB8+ T Cells in Kidney Transplant RejectionF30AI167482 · NIAID · UNIVERSITY OF CINCINNATI · PI Tiffany Shi · 2023 to 2026
$173k
NCATS NIH HHS UL1 TR000077NIAID NIH HHS F30 AI167482NIAID NIH HHS R21 AI142264NIAID NIH HHS R21 AI169863NIAMS NIH HHS UH2 AR067688NIDDK NIH HHS T32 DK007695
6 · The paper itself

Abstract

Bulk analysis of renal allograft biopsies (rBx) identified RNA transcripts associated with acute cellular rejection (ACR); however, these lacked cellular context critical to mechanistic understanding of how rejection occurs despite immunosuppression (IS). We performed combined single-cell RNA transcriptomic and TCR-α/β sequencing on rBx from patients with ACR under differing IS drugs: tacrolimus, iscalimab, and belatacept. We found distinct CD8+ T cell phenotypes (e.g., effector, memory, exhausted) depending upon IS type, particularly within expanded CD8+ T cell clonotypes (CD8EXP). Gene expression of CD8EXP identified therapeutic targets that were influenced by IS type. TCR analysis revealed a highly restricted number of CD8EXP, independent of HLA mismatch or IS type. Subcloning of TCR-α/β cDNAs from CD8EXP into Jurkat 76 cells (TCR-/-) conferred alloreactivity by mixed lymphocyte reaction. Analysis of sequential rBx samples revealed persistence of CD8EXP that decreased, but were not eliminated, after successful antirejection therapy. In contrast, CD8EXP were maintained in treatment-refractory rejection. Finally, most rBx-derived CD8EXP were also observed in matching urine samples, providing precedent for using urine-derived CD8EXP as a surrogate for those found in the rejecting allograft. Overall, our data define the clonal CD8+ T cell response to ACR, paving the next steps for improving detection, assessment, and treatment of rejection.

Indexed as

Kidney TransplantationAllograftsGraft RejectionReceptors, Antigen, T-Cell, alpha-betaRNATranscriptomeReceptors, Antigen, T-Cell, alpha-betaRNAImmunologyOrgan transplantationT cell receptorT cellsTransplantation

Identifiers

PMID37227784
PMCPMC10348771
OpenAlexW4378212993

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.